Facile Synthesis of Fluorinated
Pyrrolo[2,3-b]pyridines

Ulrich Groth; Viktor O. Iaroshenko; Yan Wang; Thomas Wesch

doi:10.1055/s-0028-1087530

LETTER

Facile Synthesis of Fluorinated Pyrrolo[2,3-b]pyridines

Ulrich Groth*, Viktor O. Iaroshenko, Yan Wang, Thomas Wesch
Fachbereich Chemie und Konstanz Research School Chemical Biology, Universität Konstanz, Fach M-720, Universitätsstr. 10, 78457 Konstanz, Germany
Fax: +49(7531)884155; e-Mail: Ulrich.groth@uni-konstanz.de;

Abstract

All articles of this category

Abstract

With the purpose to synthesize novel ADAs (adenosine deaminase) and IMPDH (inosine 5′-monophosphate dehydrogenase) inhibitors the reaction of 5-amino-1-tert-butyl-1H-pyrrolo-3-carbonitrile with fluorinated 1,3 -biselectrophiles was studied. An efficient and convenient synthetical approach to obtain fluorinated pyrrolo[2,3-b]pyridines was developed. tert-Butyl protecting group was successfully cleaved by treating of synthesized pyrrolopyridines with concentrated sulfuric acid.

Key words

pyrrol - amine - fluorine - pyridine - annulation - electrophilic aromatic substitution

Full Text

References

References and Notes

<A NAME="RG27908ST-1A">1a</A> Ugarkar BG. DaRe JM. Kopcho JJ. Browne CE. Schanzer JM. Wiesner JB. Erion MD.
J. Med. Chem. 2000, 43: 2883

<A NAME="RG27908ST-1B">1b</A> Erion MD. Ugarkar BG. DaRe JM. Castellino AJ. Fujitaki JM. Dixon R. Appleman JR. Wiesner JB. Nucleosides, Nucleotides Nucleic Acids 1997, 16: 1013

<A NAME="RG27908ST-2A">2a</A> Seela F. Zulauf M. Nucleosides, Nucleotides Nucleic Acids 1999, 18: 2697

<A NAME="RG27908ST-2B">2b</A> Renau TE. Kennedy C. Ptak RG. Breitenbach JM. Drach JC. Townsend LB. J. Med. Chem. 1996, 39: 3470

<A NAME="RG27908ST-2C">2c</A> Crawczyk SH. Renau TE. Nassiri MR. Westerman AC. Wotring LL. Drach JC. Townsend LB. J. Med. Chem. 1995, 38: 4115

<A NAME="RG27908ST-2D">2d</A> Crawczyk SH. Nassiri MR. Kucera LS. Kern ER. Ptak RG. Wotring LL. Drach JC. Townsend LB. J. Med. Chem. 1995, 38: 4106

<A NAME="RG27908ST-3A">3a</A> Nekhai S. Bhat UG. Ammosova T. Radhakrishnan SK. Jerebtsova M. Niu X. Foster A. Layden TJ. Gartel AL. Oncogene 2007, 26: 3899

<A NAME="RG27908ST-3B">3b</A> Mohapatra S, and Pledger WJ. inventors; US 2007238745. ; Chem. Abstr. 2007, 147, 420059

<A NAME="RG27908ST-3C">3c</A> Fujiwara Y. Hosokawa Y. Watanabe K. Tanimura S. Ozaki K.-I. Kohno M. Mol. Cancer Ther. 2007, 6: 1133

<A NAME="RG27908ST-4A">4a</A> Porcari AR. Ptak RG. Borysko KZ. Breitenbach JM. Drach JC. Townsend L. J. Med. Chem. 2000, 43: 2457

<A NAME="RG27908ST-4B">4b</A> Gartel AL, and Radhakrishnan SK. inventors; WO 2006116512. ; Chem. Abstr. 2006, 145, 465765

<A NAME="RG27908ST-4C">4c</A> Gordon RK. Ginalski K. Rudnicki WR. Rychlewski L. Pankaskie MC. Bujnicki JM. Chiang PK. Eur. J. Biochem. 2003, 270: 3507

<A NAME="RG27908ST-5A">5a</A> Mekouar K, Deziel R, Mounir S, and Iyer RP. inventors; WO 2003055896. ; Chem. Abstr. 2003, 139, 53249

<A NAME="RG27908ST-5B">5b</A> Schul W. Liu W. Xu H.-Y. Flamand M. Vasudevan SG. J. Infect. Dis. 2007, 195: 665

<A NAME="RG27908ST-5C">5c</A> Maccoss M, Olsen DB, Leone J, and Durette PL. inventors; WO 2006065335. ; Chem. Abstr. 2006, 145, 76603

<A NAME="RG27908ST-5D">5d</A> Maccoss M, and Olsen DB. inventors; WO 2006012078. ; Chem. Abstr. 2006, 144, 192451

<A NAME="RG27908ST-6A">6a</A> Hoffman K. Holmes FA. Fraschini G. Esparza L. Frye D. Raber MN. Newman RA. Hortobagyi GN. Cancer Chemother. Pharmacol. 1996, 37: 254

<A NAME="RG27908ST-6B">6b</A> O’Connell MJ. Rubin J. Hahn RG. Kvols LK. Moertel CG. Cancer Treat. Rep. 1987, 71: 333

<A NAME="RG27908ST-6C">6c</A> Lyss AP. Morrell LE. Perry MC. Proc. Am. Soc. Clin. Oncol. 1991, 10: 120

<A NAME="RG27908ST-6D">6d</A> Feun LG. Blessing JA. Barrett RJ. Hanjani PA. Am. J. Clin. Oncol. 1993, 16: 506

<A NAME="RG27908ST-7">7</A> Mantovanini M, Melillo G, and Daffonchio L. inventors; WO 9504742. ; Chem. Abstr. 1995, 122, 314537

<A NAME="RG27908ST-8">8</A> Easterwood LM. Veliz EA. Beal PA. J. Am. Chem. Soc. 2000, 122: 11537

<A NAME="RG27908ST-9">9</A> Veliz EA. Easterwood LM. Beal PA. J. Am. Chem. Soc. 2003, 125: 10867

<A NAME="RG27908ST-10">10</A> Cristalli G. Eleuteri A. Vittori S. Volpini R. Camaioni E. Lupidi G. Drug Dev. Res. 1993, 28: 253

<A NAME="RG27908ST-11A">11a</A> Lupidi G. Marmocchi F. Cristalli G. Biochem. Mol. Biol. 1998, 46: 1071

<A NAME="RG27908ST-11B">11b</A> Lupidi G. Cristalli G. Marmocchi F. Riva F. Grifantini M. J. Enzyme Inhib. Med. Chem. 1985, 1: 67

<A NAME="RG27908ST-11C">11c</A> Okamoto A. Tanaka K. Saito I. Bioorg. Med. Chem. Lett. 2002, 12: 97

<A NAME="RG27908ST-12">12</A> Erion MD. Reddy MR. J. Am. Chem. Soc. 1998, 120: 3295

<A NAME="RG27908ST-13A">13a</A> Begue J.-P. Bonnet-Delpon D. Chimie bioorganique et médecinal du fluor EDP Sciences; Paris: 2005. p.366

<A NAME="RG27908ST-13B">13b</A> Silverman RB. The Organic Chemistry of Drug Design, and Drug Action 2nd ed.: Elsevier Academic Press; London: 2004. p.617 ; ISBN 0-12-643732-7

<A NAME="RG27908ST-14">14</A> Agarwal RP. Spector T. Parks RE. Biochem. Pharmacol. 1977, 26: 359

<A NAME="RG27908ST-15">15</A> Pankiewicz KW. Goldstein BM. Inosine Monophosphate Dehydrogenase: ACS Symposium Series 839 American Chemical Society; Washington DC: 2003.

<A NAME="RG27908ST-16A">16a</A> Iaroshenko VO. Volochnyuk DM. Wang Y. Vovk MV. Boiko VJ. Rusanov EB. Groth UM. Tolmachev AO. Synthesis 2007, 3309

<A NAME="RG27908ST-16B">16b</A> Iaroshenko VO. Groth U. Kryvokhyzha NV. Obeid S. Tolmachev AA. Wesch T. Synlett 2008, 343

<A NAME="RG27908ST-16C">16c</A> Volochnyuk DM. Pushechnikov AO. Krotko DG. Sibgatulin DA. Kovalyova SA. Tolmachev AA. Synthesis 2003, 1531

<A NAME="RG27908ST-16D">16d</A> Vovk MV. Bolbut AV. Boiko VI. Pirozhenko VV. Chernega AN. Tolmachev AA. Chem. Heterocycl. Compd. (N.Y.) 2004, 40: 370

<A NAME="RG27908ST-16E">16e</A> Vovk MV. Bol’but AV. Dorokhov VI. Pyrozhenko VV. Synth. Commun. 2002, 32: 3749

<A NAME="RG27908ST-16F">16f</A> Wesch T. Iaroshenko VO. Groth U. Synlett 2008, 1459

<A NAME="RG27908ST-17">17</A> De Rosa M. Issac RP. Houghton G. Tetrahedron Lett. 1995, 36: 9261

<A NAME="RG27908ST-18">18</A> Allegretti M. Anacardio R. Cesta MC. Curti R. Mantovanini M. Nano G. Topai A. Zampella G. Org. Process Res. Dev. 2003, 7: 209

<A NAME="RG27908ST-19A">19a</A> Brodrick A. Wibberley DG. J. Chem Soc., Perkin Trans. 1 1975, 19: 1910

<A NAME="RG27908ST-19B">19b</A> Benoit R. Dupas G. Bourguignon J. Queguiner G. Synthesis 1987, 1124

1- tert -Butyl-4-[chloro(difluoro)methyl]-6-phenyl-1 H -pyrrolo[2,3- b ]pyridine-3-carbonitrile (11e)
Colorless solid (0.65g, 90%); mp 234 ˚C (from EtOH). ^¹H NMR (400 MHz, DMSO-d ₆): δ = 1.87 (9 H, s, CH₃), 7.53
(3 H, br m), 8.07 (1 H, s), 8.18 (2 H, d, ^³ J _CH = 7.8 Hz), 8.70 (1 H, s). ^¹³C NMR (100.5 MHz, DMSO-d ₆): δ = 28.9, 59.5, 81.9, 109.4 (t, ^³ J _CF = 6.4 Hz), 112.8 (t, ^³ J _CF = 2.4 Hz), 114.9, 124.6, (t, ^¹ J _CF = 290 Hz), 126.9, 129.0, 129.6, 135.2 (t, ^² J _CF = 30 Hz), 137.8, 139.7, 148.0, 151.3. MS: m/z (%) = 361(13) [M⁺ + 2], 359(36) [M⁺], 304(23), 303(100), 269(16), 268(75), 57(13). Anal. Calcd for C₁₉H₁₆ClF₂N₃: C, 63.42; H, 4.48; Cl, 9.85; F, 10.56; N, 11.68. Found: C, 63.50; H, 4.53; N, 11.75.

The General Procedure for Synthesis of Pyrrolo[2,3- b ]pyridines 11 and 13 5-Amino-1-tert-butyl-1H-pyrrole-3-carbonitrile (0.33 g, 2 mmol) and diketone 10 (or 12, 2.2 mmol) were dissolved in AcOH (20 mL) and heated under reflux in the inert atmosphere during 1 h. Then this solution was evaporated under reduced pressure, treated with H₂O, filtrated, and dried on the air and recrystallized from an appropriate solvent, or was subjected to column chromatography over SiO₂.

<A NAME="RG27908ST-22A">22a</A> Zanatta N. Amaral SS. Esteves-Souza A. Echevarria A. Brondani PB. Flores DC. Bonacorso HG. Flores AFC. Martins MAP. Synthesis 2006, 2305

<A NAME="RG27908ST-22B">22b</A> Kondratov IS. Gerus II. Kacharov AD. Gorbunova MG. Kukhar VP. Froehlich R. J. Fluorine Chem. 2005, 126: 543

<A NAME="RG27908ST-22C">22c</A> Matsumoto N. Takahashi M. Tetrahedron Lett. 2005, 46: 5551

The Procedure for the Synthesis of ( E )-1- tert -Butyl-5-(4,4,4-trifluoro-3-oxobut-1-enylamino)-1 H -pyrrole-3-carbonitrile (15) 5-Amino-1-tert-butyl-1H-pyrrole-3-carbonitrile (0.66 g,
4 mmol) and 14 (0.68 g, 4.4 mmol) were dissolved in abs. DMF (10 mL) and heated under inert atmosphere at 85 ˚C for 12 h. The solution was evaporated under reduced pressure, treated with H₂O, and dried under reduced pressure. Afterwards, the residue was subjected to column chromatography over SiO₂. Colorless solid (0.78 g, 68%); mp 116-118 ˚C; R _f = 0.75 (hexane-EtOAc, 5:1). ^¹H NMR (400 MHz, CDCl₃): d = 1.59 (9 H, s, CH₃), 5.68 (1 H, d, ^³ J _HH = 8 Hz), 6.20 (1 H, s.), 7.13 (1 H, s), 7.29 (1 H, dd, ^³ J _HH = 8 Hz, ^³ J _HH = 4 Hz), 11.80
(1 H, d, ^³ J _HH = 4 Hz, NH). ^¹³C NMR (100.5 MHz, CDCl₃): d = 29.9, 58.1, 90.7, 91.0, 103.7, 119.8 (d, ^¹ J _CF = 285 Hz), 117.7, 131.0, 140.7, 153.3, 180.2 (q, ^² J _CF = 33 Hz). MS: m/z (%) = 286(11) [M⁺ + 1], 285(56) [M⁺], 239(22), 229(77), 170(11), 160(90), 57(100), 41(37). Anal. Calcd for C₁₃H₁₄F₃N₃O: C, 54.73; H, 4.95; F, 19.98; N, 14.73; O, 5.61. Found: C, 54.80; H, 4.98; N, 14.78.

Procedure for the Synthesis of 1- tert -Butyl-4-(trifluoro-methyl)-1 H -pyrrolo[2,3- b ]pyridine-3-carbonitrile (16)
1-tert-Butyl-5-(4,4,4-trifluoro-3-oxobut-1-enylamino)-1H-pyrrole-3-carbonitrile (15, 0.57 g, 2 mmol) in a 10 mL flask was melted for 5 h under inert atmosphere at 180 ˚C (temperature of the oil bath), then the dark-green residue formed was subjected to column chromatography over SiO₂.
Colorless solid (0.38 g, 71%); mp 161-163 ˚C. R _f = 0.75 (hexane-EtOAc, 5:1). ^¹H NMR (400 MHz, CDCl₃): δ = 1.78 (9 H, s, CH₃), 7.41 (1 H, d, ^³ J _HH = 4.7 Hz, H), 7.99 (1 H, s), 8.49 (1 H, d, ^³ J _HH = 4.7 Hz). ^¹³C NMR (100.5 MHz, CDCl₃): δ = 29.0, 59.3, 82.8, 113.8 (q, ^³ J _CF = 4.7 Hz), 114.5, 115.7, 122.8 (q, ^² J _CF = 270 Hz), 129.8 (q, ^² J _CF = 35 Hz), 136.3, 143.7, 148.3. MS: m/z (%) = 267(48) [M⁺], 212(58), 211(100), 192(24), 57(39), 56(10), 41(25). Anal. Calcd for C₁₃H₁₂F₃N₃: C, 58.42; H, 4.53; F, 21.33; N, 15.72. Found: C, 58.50; H, 4.59; N, 15.71.

Crystallographic data (excluding structure factors) for the structure11c reported in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication no. CCDC 683574 and can be obtained free of charge on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44(1223)336033; email: deposit@ccdc.cam.ac.uk, or via www.ccdc.cam.ac.uk/data_request/cif.